// Reproductive/Gynecology - Drugs
// Auto-generated from modularize-data.js

const drugs = [
    {
        "id": "ethinyl-estradiol-norethindrone",
        "name": "Ethinyl Estradiol/Norethindrone",
        "pharmacologicClass": "combined-oral-contraceptives",
        "therapeuticClass": "hormonal-contraceptives",
        "system": "reproductive-gynecology",
        "mechanism": "Estrogen and progestin suppress LH/FSH, prevent ovulation.",
        "features": "First-generation progestin combination.",
        "clinicalChoice": "Contraception, menstrual regulation.",
        "indications": [
            "Contraception",
            "Menstrual Irregularities"
        ],
        "contraindications": [
            "Thromboembolism History",
            "Smoking >35 years"
        ],
        "sideEffects": [
            "Thromboembolism",
            "Hypertension",
            "Breast tenderness",
            "Nausea"
        ],
        "interactions": "CYP450 inducers reduce efficacy, antibiotics may reduce efficacy.",
        "interactionDetails": "CYP450 INDUCERS: MECHANISM - Rifampin, phenytoin increase hepatic metabolism of contraceptive hormones, reducing levels. CONSEQUENCE - Breakthrough bleeding and contraceptive failure. Use backup contraception.",
        "pageType": "drug"
    },
    {
        "id": "ethinyl-estradiol-levonorgestrel",
        "name": "Ethinyl Estradiol/Levonorgestrel",
        "pharmacologicClass": "combined-oral-contraceptives",
        "therapeuticClass": "hormonal-contraceptives",
        "system": "reproductive-gynecology",
        "mechanism": "Estrogen and progestin suppress LH/FSH, prevent ovulation.",
        "features": "Second-generation progestin, androgenic.",
        "clinicalChoice": "Contraception with good cycle control.",
        "indications": [
            "Contraception"
        ],
        "contraindications": [
            "Thromboembolism History",
            "Severe Hypertension"
        ],
        "sideEffects": [
            "Thromboembolism",
            "Hypertension",
            "Breast tenderness",
            "Nausea"
        ],
        "interactions": "CYP450 inducers reduce efficacy, antibiotics may reduce efficacy.",
        "interactionDetails": "CYP450 INDUCERS: MECHANISM - Rifampin, phenytoin increase hepatic metabolism of contraceptive hormones, reducing levels. CONSEQUENCE - Breakthrough bleeding and contraceptive failure. Use backup contraception.",
        "pageType": "drug"
    },
    {
        "id": "ethinyl-estradiol-drospirenone",
        "name": "Ethinyl Estradiol/Drospirenone",
        "pharmacologicClass": "combined-oral-contraceptives",
        "therapeuticClass": "hormonal-contraceptives",
        "system": "reproductive-gynecology",
        "mechanism": "Estrogen and progestin suppress LH/FSH, prevent ovulation.",
        "features": "Anti-androgenic progestin, antimineralocorticoid.",
        "clinicalChoice": "PMDD, acne, contraception.",
        "indications": [
            "Contraception",
            "PMDD",
            "Acne"
        ],
        "contraindications": [
            "Renal Impairment",
            "Hyperkalemia"
        ],
        "sideEffects": [
            "Thromboembolism",
            "Hypertension",
            "Breast tenderness",
            "Nausea"
        ],
        "interactions": "CYP450 inducers reduce efficacy, antibiotics may reduce efficacy.",
        "interactionDetails": "CYP450 INDUCERS: MECHANISM - Rifampin, phenytoin increase hepatic metabolism of contraceptive hormones, reducing levels. CONSEQUENCE - Breakthrough bleeding and contraceptive failure. Use backup contraception.",
        "pageType": "drug"
    },
    {
        "id": "norethindrone-mini-pill",
        "name": "Norethindrone (Mini-pill)",
        "pharmacologicClass": "progestin-only-contraceptives",
        "therapeuticClass": "hormonal-contraceptives",
        "system": "reproductive-gynecology",
        "mechanism": "Thicken cervical mucus, thin endometrium, some ovulation suppression.",
        "features": "Daily oral progestin-only pill.",
        "clinicalChoice": "Breastfeeding, estrogen contraindications.",
        "indications": [
            "Contraception in Breastfeeding"
        ],
        "contraindications": [
            "Active Liver Disease",
            "Breast Cancer"
        ],
        "sideEffects": [
            "Irregular bleeding",
            "Weight gain",
            "Mood changes"
        ],
        "interactions": "CYP450 inducers reduce efficacy.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "medroxyprogesterone-depo",
        "name": "Medroxyprogesterone (Depo)",
        "pharmacologicClass": "progestin-only-contraceptives",
        "therapeuticClass": "hormonal-contraceptives",
        "system": "reproductive-gynecology",
        "mechanism": "Thicken cervical mucus, thin endometrium, some ovulation suppression.",
        "features": "Injectable, 3-month duration.",
        "clinicalChoice": "Long-acting contraception, compliance issues.",
        "indications": [
            "Long-Term Contraception"
        ],
        "contraindications": [
            "Osteoporosis",
            "Breast Cancer"
        ],
        "sideEffects": [
            "Irregular bleeding",
            "Weight gain",
            "Mood changes"
        ],
        "interactions": "CYP450 inducers reduce efficacy.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "levonorgestrel-iud",
        "name": "Levonorgestrel IUD",
        "pharmacologicClass": "progestin-only-contraceptives",
        "therapeuticClass": "hormonal-contraceptives",
        "system": "reproductive-gynecology",
        "mechanism": "Thicken cervical mucus, thin endometrium, some ovulation suppression.",
        "features": "Intrauterine, 5-year duration.",
        "clinicalChoice": "Long-term contraception, heavy periods.",
        "indications": [
            "Long-Term Contraception",
            "Heavy Menstrual Bleeding"
        ],
        "contraindications": [
            "PID",
            "Distorted Uterine Cavity"
        ],
        "sideEffects": [
            "Irregular bleeding",
            "Weight gain",
            "Mood changes"
        ],
        "interactions": "CYP450 inducers reduce efficacy.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "estradiol",
        "name": "Estradiol",
        "pharmacologicClass": "estrogens",
        "therapeuticClass": "reproductive-hormones",
        "system": "reproductive-gynecology",
        "mechanism": "Estrogen receptor agonists, multiple physiologic effects.",
        "features": "Bioidentical estrogen, multiple formulations.",
        "clinicalChoice": "Menopausal hormone therapy.",
        "indications": [
            "Menopausal Symptoms",
            "Osteoporosis Prevention"
        ],
        "contraindications": [
            "Breast Cancer",
            "Thromboembolism History"
        ],
        "sideEffects": [
            "Thromboembolism",
            "Breast cancer risk",
            "Endometrial hyperplasia"
        ],
        "interactions": "CYP450 inducers reduce levels.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "conjugated-estrogens",
        "name": "Conjugated Estrogens",
        "pharmacologicClass": "estrogens",
        "therapeuticClass": "reproductive-hormones",
        "system": "reproductive-gynecology",
        "mechanism": "Estrogen receptor agonists, multiple physiologic effects.",
        "features": "Mixed estrogens from pregnant mare urine.",
        "clinicalChoice": "Menopausal symptoms, postmenopausal osteoporosis.",
        "indications": [
            "Menopausal Symptoms",
            "Atrophic Vaginitis"
        ],
        "contraindications": [
            "Breast Cancer",
            "Liver Disease"
        ],
        "sideEffects": [
            "Thromboembolism",
            "Breast cancer risk",
            "Endometrial hyperplasia"
        ],
        "interactions": "CYP450 inducers reduce levels.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "progesterone",
        "name": "Progesterone",
        "pharmacologicClass": "progestins",
        "therapeuticClass": "reproductive-hormones",
        "system": "reproductive-gynecology",
        "mechanism": "Progesterone receptor agonists, oppose estrogen effects.",
        "features": "Bioidentical, multiple routes available.",
        "clinicalChoice": "Luteal phase support, HRT.",
        "indications": [
            "Luteal Phase Deficiency",
            "Menopausal HRT"
        ],
        "contraindications": [
            "Breast Cancer",
            "Liver Disease"
        ],
        "sideEffects": [
            "Weight gain",
            "Mood changes",
            "Breast tenderness"
        ],
        "interactions": "CYP450 interactions vary by agent.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "medroxyprogesterone",
        "name": "Medroxyprogesterone",
        "pharmacologicClass": "progestins",
        "therapeuticClass": "reproductive-hormones",
        "system": "reproductive-gynecology",
        "mechanism": "Progesterone receptor agonists, oppose estrogen effects.",
        "features": "Synthetic progestin, oral and injectable.",
        "clinicalChoice": "Abnormal uterine bleeding, contraception.",
        "indications": [
            "Abnormal Uterine Bleeding",
            "Contraception"
        ],
        "contraindications": [
            "Pregnancy",
            "Breast Cancer"
        ],
        "sideEffects": [
            "Weight gain",
            "Mood changes",
            "Breast tenderness"
        ],
        "interactions": "CYP450 interactions vary by agent.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "oxytocin",
        "name": "Oxytocin",
        "pharmacologicClass": "oxytocics",
        "therapeuticClass": "labor-and-delivery",
        "system": "reproductive-gynecology",
        "mechanism": "Stimulate uterine contractions via oxytocin receptors.",
        "features": "Endogenous hormone, IV/IM administration.",
        "clinicalChoice": "Labor induction, postpartum hemorrhage.",
        "indications": [
            "Labor Induction",
            "Postpartum Hemorrhage"
        ],
        "contraindications": [
            "Fetal Distress",
            "Placenta Previa"
        ],
        "sideEffects": [
            "Uterine rupture",
            "Water intoxication",
            "Hypotension"
        ],
        "interactions": "Vasoconstrictors (severe hypertension).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "methylergonovine",
        "name": "Methylergonovine",
        "pharmacologicClass": "oxytocics",
        "therapeuticClass": "labor-and-delivery",
        "system": "reproductive-gynecology",
        "mechanism": "Stimulate uterine contractions via oxytocin receptors.",
        "features": "Ergot alkaloid, prolonged uterine contraction.",
        "clinicalChoice": "Postpartum hemorrhage, incomplete abortion.",
        "indications": [
            "Postpartum Hemorrhage"
        ],
        "contraindications": [
            "Hypertension",
            "Labor Induction"
        ],
        "sideEffects": [
            "Uterine rupture",
            "Water intoxication",
            "Hypotension"
        ],
        "interactions": "Vasoconstrictors (severe hypertension).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "terbutaline",
        "name": "Terbutaline",
        "pharmacologicClass": "tocolytics",
        "therapeuticClass": "labor-and-delivery",
        "system": "reproductive-gynecology",
        "mechanism": "Suppress uterine contractions to delay preterm labor.",
        "features": "β2-agonist, off-label use for tocolysis.",
        "clinicalChoice": "Acute tocolysis, short-term use only.",
        "indications": [
            "Preterm Labor"
        ],
        "contraindications": [
            "Maternal Heart Disease",
            "Severe Preeclampsia"
        ],
        "sideEffects": [
            "Pulmonary edema",
            "Tachycardia",
            "Hyperglycemia"
        ],
        "interactions": "Beta-agonists with corticosteroids increase pulmonary edema risk.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "nifedipine",
        "name": "Nifedipine",
        "pharmacologicClass": "tocolytics",
        "therapeuticClass": "labor-and-delivery",
        "system": "reproductive-gynecology",
        "mechanism": "Suppress uterine contractions to delay preterm labor.",
        "features": "Calcium channel blocker, oral administration.",
        "clinicalChoice": "Tocolysis maintenance therapy.",
        "indications": [
            "Preterm Labor"
        ],
        "contraindications": [
            "Maternal Hypotension"
        ],
        "sideEffects": [
            "Pulmonary edema",
            "Tachycardia",
            "Hyperglycemia"
        ],
        "interactions": "Beta-agonists with corticosteroids increase pulmonary edema risk.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "sildenafil",
        "name": "Sildenafil",
        "pharmacologicClass": "pde5-inhibitors",
        "therapeuticClass": "erectile-dysfunction",
        "system": "reproductive-gynecology",
        "mechanism": "Inhibit phosphodiesterase-5, increasing cGMP levels and causing vasodilation.",
        "features": "First PDE5 inhibitor, 4-hour duration.",
        "clinicalChoice": "Erectile dysfunction, pulmonary hypertension.",
        "indications": [
            "Erectile Dysfunction",
            "Pulmonary Hypertension"
        ],
        "contraindications": [
            "Nitrate Use",
            "Severe Cardiac Disease"
        ],
        "sideEffects": [
            "Headache",
            "Flushing",
            "Nasal congestion",
            "Visual disturbances"
        ],
        "interactions": "Nitrates (severe hypotension), alpha-blockers (hypotension).",
        "interactionDetails": "NITRATES: MECHANISM - Nitrates increase cGMP levels through nitric oxide release. PDE5 inhibitors prevent cGMP breakdown by inhibiting phosphodiesterase-5. CONSEQUENCE - Synergistic vasodilation leads to severe, potentially life-threatening hypotension that may not respond to fluids and requires vasopressors.",
        "pageType": "drug"
    },
    {
        "id": "tadalafil",
        "name": "Tadalafil",
        "pharmacologicClass": "pde5-inhibitors",
        "therapeuticClass": "erectile-dysfunction",
        "system": "reproductive-gynecology",
        "mechanism": "Inhibit phosphodiesterase-5, increasing cGMP levels and causing vasodilation.",
        "features": "Longest duration (36 hours), daily dosing option.",
        "clinicalChoice": "ED with desire for spontaneity.",
        "indications": [
            "Erectile Dysfunction",
            "BPH"
        ],
        "contraindications": [
            "Nitrate Use",
            "Severe Hepatic Impairment"
        ],
        "sideEffects": [
            "Headache",
            "Flushing",
            "Nasal congestion",
            "Visual disturbances"
        ],
        "interactions": "Nitrates (severe hypotension), alpha-blockers (hypotension).",
        "interactionDetails": "NITRATES: MECHANISM - Nitrates increase cGMP levels through nitric oxide release. PDE5 inhibitors prevent cGMP breakdown by inhibiting phosphodiesterase-5. CONSEQUENCE - Synergistic vasodilation leads to severe, potentially life-threatening hypotension that may not respond to fluids and requires vasopressors.",
        "pageType": "drug"
    },
    {
        "id": "vardenafil",
        "name": "Vardenafil",
        "pharmacologicClass": "pde5-inhibitors",
        "therapeuticClass": "erectile-dysfunction",
        "system": "reproductive-gynecology",
        "mechanism": "Inhibit phosphodiesterase-5, increasing cGMP levels and causing vasodilation.",
        "features": "Intermediate duration, less visual side effects.",
        "clinicalChoice": "ED in patients with visual concerns.",
        "indications": [
            "Erectile Dysfunction"
        ],
        "contraindications": [
            "Nitrate Use",
            "QT Prolongation"
        ],
        "sideEffects": [
            "Headache",
            "Flushing",
            "Nasal congestion",
            "Visual disturbances"
        ],
        "interactions": "Nitrates (severe hypotension), alpha-blockers (hypotension).",
        "interactionDetails": "NITRATES: MECHANISM - Nitrates increase cGMP levels through nitric oxide release. PDE5 inhibitors prevent cGMP breakdown by inhibiting phosphodiesterase-5. CONSEQUENCE - Synergistic vasodilation leads to severe, potentially life-threatening hypotension that may not respond to fluids and requires vasopressors.",
        "pageType": "drug"
    }
];

export default drugs;
